European Journal of Molecular & Clinical Medicine

Background and Aim: Since the onset of the 2019-nCoV disease (COVID-19), many skin
manifestations have been reported in COVID-19 patients. This study aims to analysis of various skin
manifestations among patients with COVID-19.
Methods: An observational study was conducted in department of dermatology, Bharatpur Medical
College & Hospital, Bharatpur.
Results: Among Covid positive patients 47% had maculopapular eruptions, 19%, 19% each had
urticarial and pseudo chilblains, 9% had pedicular eruptions and only 6% had necrotic lesions and they
present within 1-4 week. There is a significant association between gender and skin lesions, co morbidity
and skin lesions.
Conclusion: Infection with 2019-nCoV may lead to skin manifestations with various clinical symptoms.
These clinical features combined with clinical symptoms of COVID-19 may aid in the timely diagnosis
of patients with COVID-19.

It is well known that one of the leading causes of death among the population is cardiovascular disease, and they are often complicated by CHF.
In European countries, the prevalence of CHF is 2.1%, with 90% of women over the age of 70 and 75% of men. In the United States, these numbers range from 1–1.5% and occur in 10% of the population over the age of 60.
According to a number of leading researchers around the world, the inclusion of concomitant diseases in CHF not only worsens its overall outcome, increases the number and duration of hospital treatments , but in some cases is also the leading cause of death. Some authors compare the dynamics of deaths observed in CHF with deaths due to oncological diseases.